These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
749 related articles for article (PubMed ID: 9552031)
41. Pilot study of concurrent chemotherapy and radiotherapy for stage IV nasopharyngeal cancer. Lin JC; Jan JS; Hsu CY Am J Clin Oncol; 1997 Feb; 20(1):6-10. PubMed ID: 9020279 [TBL] [Abstract][Full Text] [Related]
42. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Katori H; Tsukuda M; Watai K Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160 [TBL] [Abstract][Full Text] [Related]
43. Therapeutic results of alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil: its usefulness and controversial points. Fuwa N; Ito Y; Kodaira T; Matsumoto A; Kamata M; Furutani K; Tatibana H; Sasaoka M; Morita K Jpn J Clin Oncol; 2001 Dec; 31(12):589-95. PubMed ID: 11902489 [TBL] [Abstract][Full Text] [Related]
44. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A. Sundfør K; Tropé CG; Högberg T; Onsrud M; Koern J; Simonsen E; Bertelsen K; Westberg R Cancer; 1996 Jun; 77(11):2371-8. PubMed ID: 8635109 [TBL] [Abstract][Full Text] [Related]
45. Selective Radiotherapy after Distant Metastasis of Nasopharyngeal Carcinoma Treated with Dose-Dense Cisplatin plus Fluorouracil. Liang Y; Bu JG; Cheng JL; Gao WW; Xu YC; Feng J; Chen BY; Liang WC; Chen KQ Asian Pac J Cancer Prev; 2015; 16(14):6011-7. PubMed ID: 26320489 [TBL] [Abstract][Full Text] [Related]
46. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516). Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460 [TBL] [Abstract][Full Text] [Related]
47. [Concurrent chemoradiotherapy followed by adjuvant chemotherapy for stage III-IVa nasopharyngeal carcinoma]. Hu QY; Liu P; Wang L; Fu ZF Ai Zheng; 2007 Apr; 26(4):394-7. PubMed ID: 17430659 [TBL] [Abstract][Full Text] [Related]
48. Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated carcinoma of the nasopharynx: optimal compliance and promising 4-year results. Ponzanelli A; Vigo V; Marcenaro M; Bacigalupo A; Gatteschi B; Ravetti JL; Corvò R; Benasso M Oral Oncol; 2008 Aug; 44(8):767-74. PubMed ID: 18061519 [TBL] [Abstract][Full Text] [Related]
49. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix]. Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134 [TBL] [Abstract][Full Text] [Related]
50. Long-term outcomes of a phase II randomized controlled trial comparing intensity-modulated radiotherapy with or without weekly cisplatin for the treatment of locally recurrent nasopharyngeal carcinoma. Guan Y; Liu S; Wang HY; Guo Y; Xiao WW; Chen CY; Zhao C; Lu TX; Han F Chin J Cancer; 2016 Feb; 35():20. PubMed ID: 26879049 [TBL] [Abstract][Full Text] [Related]
51. Nasopharyngeal carcinoma in childhood and adolescence: concept and preliminary results of the cooperative GPOH study NPC-91. Gesellschaft für Pädiatrische Onkologie und Hämatologie. Mertens R; Granzen B; Lassay L; Gademann G; Hess CF; Heimann G Cancer; 1997 Sep; 80(5):951-9. PubMed ID: 9307197 [TBL] [Abstract][Full Text] [Related]
52. [Concomitant bifractionated radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in locally progressive, non-resectable epidermoid carcinomas of the pharynx: ten years experience at the Antoine Lacassagne center]. Magné N; Pivot X; Marcy PY; Chauvel P; Courdi A; Dassonville O; Poissonnet G; Vallicioni J; Ettore F; Falewee MN; Milano G; Santini J; Lagrange JL; Schneider M; Demard F; Bensadoun RJ Cancer Radiother; 2001 Aug; 5(4):413-24. PubMed ID: 11521390 [TBL] [Abstract][Full Text] [Related]
53. Carboplatin/5-fluorouracil as an alternative to cisplatin/5- fluorouracil for metastatic and recurrent head and neck squamous cell carcinoma and nasopharyngeal carcinoma. Kua VF; Ismail F; Chee Ee Phua V; Aslan NM Asian Pac J Cancer Prev; 2013; 14(2):1121-6. PubMed ID: 23621198 [TBL] [Abstract][Full Text] [Related]
54. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. Wendt TG; Grabenbauer GG; Rödel CM; Thiel HJ; Aydin H; Rohloff R; Wustrow TP; Iro H; Popella C; Schalhorn A J Clin Oncol; 1998 Apr; 16(4):1318-24. PubMed ID: 9552032 [TBL] [Abstract][Full Text] [Related]
55. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial. Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739 [TBL] [Abstract][Full Text] [Related]
56. Intensive short cause chemotherapy followed by radiotherapy of locally advanced nasopharyngeal carcinoma. Zidan J; Kuten A; Robinson E Cancer; 1996 May; 77(10):1973-7. PubMed ID: 8640658 [TBL] [Abstract][Full Text] [Related]
57. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma. Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559 [TBL] [Abstract][Full Text] [Related]
58. Efficacy and safety of concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced nasopharyngeal cancers. Baykara M; Buyukberber S; Ozturk B; Coskun U; Kaplan MA; Unsal DK; Dane F; Demirci U; Bora H; Benekli M; Tumori; 2013; 99(4):469-73. PubMed ID: 24326834 [TBL] [Abstract][Full Text] [Related]
59. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up. Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029 [TBL] [Abstract][Full Text] [Related]
60. Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation. Fountzilas G; Ciuleanu E; Bobos M; Kalogera-Fountzila A; Eleftheraki AG; Karayannopoulou G; Zaramboukas T; Nikolaou A; Markou K; Resiga L; Dionysopoulos D; Samantas E; Athanassiou H; Misailidou D; Skarlos D; Ciuleanu T Ann Oncol; 2012 Feb; 23(2):427-35. PubMed ID: 21525406 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]